RCUS - Arcus Biosciences Inc. (RCUS) Q1 2024 Earnings Call Transcript

2024-05-08 21:55:26 ET

Arcus Biosciences, Inc. (RCUS)

Q1 2024 Earnings Conference Call

May 8, 2024 4:30 PM ET

Company Participants

Pia Eaves - Vice President of Investor Relations & Strategy

Terry Rosen - CEO

Jennifer Jarrett - COO

Bob Goeltz - CFO

Dimitry Nuyten - CMO

Juan Jaen - President

Conference Call Participants

Kaveri Pohlman - BTIG

Peter Lawson - Barclays

Ashiq Mubarack - Citi

Jonathan Miller - Evercore ISI

Jason Zemansky - Bank of America

Jeff La Rosa - Leerink Partners

Rosemary Li - Cantor Fitzgerald

Presentation

Operator

Hello, all and welcome to Arcus Biosciences First Quarter 2024 Earnings Call. My name is Lydia, and I’ll be your operator today. [Operator Instructions]

I’ll now hand you over to Pia Eaves, Vice President of Investor Relations & Strategy.

Pia Eaves

Hello, everyone and thank you for joining us on today’s conference call to discuss Arcus’s first quarter 2024 financial results and pipeline updates. I’d like to remind you that on this call, management will make forward-looking statements, including statements about our cash runway and our expected clinical development milestones and timelines.

All statements other than historical facts reflect the current beliefs and expectations of management and involve risks and uncertainties that may cause our actual results to differ from those expressed. Those risks and uncertainties are described in our annual report on Form 10-K and quarterly report on Form 10-Q, which have been filed with the SEC. We strongly encourage you to review our filings.

Today, you’ll hear from our CEO, Terry Rosen; COO, Jennifer Jarrett; and CFO, Bob Goeltz, will also be joined by our; CMO, Dimitry Nuyten; and President, Juan Jaen for questions after the prepared remarks.

For ease of listening, we’ll be referring to abbreviations of our molecule names, domvanalimab as dom, zimberelimab as zim, casdatifan as cas, quemliclustat as quemli, and etrumadenant as etruma. During today’s call, we’ll refer to slides in our corporate deck, which can be found on the Investors section of our website....

For further details see: